Christian Foglar, MD
Orthopedic Surgery · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 8 carriers
- Offices
- 2
Offices
2 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: Good Samaritan Hospital · Natividad Medical Center · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
26 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Foglar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Florida ME84652Medical Doctor · since 2002 · expires 2028-01-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
3 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Orthopaedic Surgery
Education
- Universitat Basel · MD1989Medical school
Residency and fellowship
- Baylor College of Medicine, OTHERHouston, TX · 1995–1996
- UCLA Harbor MC, SURGERYTorrance, CA · 1994–1995
- University of California, ORTHOPEDICSSan Francisco, CA · from 1995
What else the board holds
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
California
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Natividad Medical CenterSalinas, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Natividad Medical CenterPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.316, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Natividad Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.316 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 332 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.18 (0.76 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.77 (109.76 to 221.78) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 609 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.48) · 2,445 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.36 (2.03 to 6.7) · 564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.44 to 3.71) · 555 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.67 (1.19 to 20.15) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.92 (0.71 to 9.12) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.07 (0.12 to 2.02) · 1,742 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.462 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 62 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.4 · 93 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7.3 · 121 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.9) · 162 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 72 cases | No different | Jan 2024 – Dec 2024 |
What patients said (966 patients answered, 55% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$155,180
Medicare paid this office $155,180 for 238 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 166 | $36,308 | $113 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 107 | $16,750 | $93 |
| Replacement of knee joint, both sides of knee | 12 | $15,314 | $1,178 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 18 | $7,617 | None |
| Short return visit (20+ min) | 64 | $7,439 | $81 |
See all 16 services
| Return visit (30+ min) | 166 | $36,308 | $113 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 107 | $16,750 | $93 |
| Replacement of knee joint, both sides of knee | 12 | $15,314 | $1,178 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 18 | $7,617 | None |
| Short return visit (20+ min) | 64 | $7,439 | $81 |
| New patient visit (45+ min) | 44 | $6,355 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,384 | $157 |
| Long return visit (40+ min) | 22 | $3,791 | $158 |
| X-ray of knee, 1-2 views | 47 | $2,570 | $33 |
| Computer-assisted surgery for muscle and bone procedure | 17 | $2,282 | $127 |
| X-ray of hip, 2-3 views | 20 | $1,497 | $52 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 14 | $1,476 | $67 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 11 | $1,444 | $90 |
| X-ray of shoulder, minimum of 2 views | 14 | $673 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 110 | $464 | None |
| Imaging guidance for procedure, 60 minutes or less | 20 | $277 | $13 |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
238 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 14% · Women 71% · Also on Medicaid 40% · Health risk score 1.29. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 34% · Coronary heart disease 28% · Depression 27% · Chronic kidney disease 21% · Atrial fibrillation 18% · Heart failure 16% · COPD 12% · Dementia 12% · Cancer 11% · Stroke 7%.
The office billed $664,853, Medicare allowed $204,500 and paid $155,180; for 2,834 services of 75 kinds; $8,081 of it was for drugs given in the office and $147,100 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 238 | 2,834 | 74 | 1.29 | $664,853 | $155,180 |
| 2023 | 236 | 2,571 | 75 | 1.32 | $716,589 | $174,441 |
| 2022 | 272 | 2,508 | 75 | 1.22 | $720,132 | $170,486 |
| 2021 | 320 | 2,546 | 74 | 1.16 | $665,603 | $172,817 |
| 2020 | 310 | 2,103 | 74 | 1.43 | $639,901 | $163,391 |
| 2019 | 297 | 2,100 | 73 | 1.32 | $673,257 | $162,560 |
| 2018 | 325 | 2,436 | 72 | 1.38 | $719,730 | $168,875 |
| 2017 | 300 | 1,954 | 73 | 1.43 | $759,600 | $167,607 |
| 2016 | 263 | 1,650 | 72 | 1.43 | $692,383 | $144,200 |
| 2015 | 286 | 1,876 | 72 | 1.44 | $941,356 | $184,359 |
| 2014 | 288 | 3,169 | 72 | 1.49 | $1,064,195 | $204,376 |
| 2013 | 307 | 2,582 | 72 | 1.55 | $1,026,510 | $224,927 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Return visit (30+ min) | 150 | $38,536 | $116 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 95 | $17,114 | $96 |
| Replacement of knee joint, both sides of knee | 12 | $14,369 | $1,197 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 21 | $8,889 | None |
| Short return visit (20+ min) | 64 | $8,030 | $80 |
| New patient visit (45+ min) | 49 | $7,450 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $6,077 | $148 |
| Long return visit (40+ min) | 28 | $5,762 | $165 |
| X-ray of knee, 1-2 views | 50 | $2,536 | $36 |
| X-ray of hip, 2-3 views | 25 | $2,023 | $51 |
| Computer-assisted surgery for muscle and bone procedure | 15 | $1,948 | $130 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 12 | $1,723 | $75 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 14 | $1,439 | $80 |
| X-ray of shoulder, minimum of 2 views | 20 | $962 | $37 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $813 | $45 |
| Imaging guidance for procedure, 60 minutes or less | 19 | $322 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 102 | $170 | None |
2022: 18 services
| Return visit (30+ min) | 162 | $36,177 | $114 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 112 | $20,484 | $94 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 12 | $12,643 | $1,054 |
| Short return visit (20+ min) | 90 | $11,106 | $76 |
| New patient visit (45+ min) | 61 | $8,489 | $139 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 16 | $7,688 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,229 | $181 |
| Long return visit (40+ min) | 37 | $6,109 | $153 |
| X-ray of hip, 2-3 views | 32 | $2,149 | $47 |
| X-ray of knee, 1-2 views | 32 | $1,452 | $36 |
| Computer-assisted surgery for muscle and bone procedure | 11 | $1,432 | $130 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 13 | $1,283 | $75 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 12 | $1,254 | $90 |
| X-ray of shoulder, minimum of 2 views | 22 | $1,109 | $34 |
| X-ray of wrist, 2 views | 11 | $956 | $37 |
| X-ray of both knees while standing | 18 | $797 | $44 |
| Imaging guidance for procedure, 60 minutes or less | 19 | $275 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 124 | $212 | None |
2021: 19 services
| Return visit (30+ min) | 186 | $41,416 | $117 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 112 | $19,605 | $94 |
| Short return visit (20+ min) | 104 | $13,115 | $79 |
| New patient visit (45+ min) | 77 | $11,445 | $149 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 14 | $8,322 | None |
| Long return visit (40+ min) | 28 | $6,104 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,128 | $184 |
| New patient visit (30+ min) | 27 | $2,246 | $83 |
| New patient visit (60+ min) | 11 | $2,141 | $195 |
| X-ray of hip, 2-3 views | 28 | $2,132 | $50 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,869 | $117 |
| X-ray of shoulder, minimum of 2 views | 34 | $1,803 | $37 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 13 | $1,397 | $78 |
| X-ray of knee, 1-2 views | 28 | $1,183 | $37 |
| X-ray of knee, 3 views | 23 | $1,095 | $44 |
| New patient visit (15+ min) | 18 | $927 | $52 |
| X-ray of wrist, 2 views | 12 | $803 | $37 |
| Imaging guidance for procedure, 60 minutes or less | 18 | $251 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 122 | $209 | None |
2020: 19 services
| Return visit (30+ min) | 159 | $28,180 | $89 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 89 | $16,809 | $87 |
| Short return visit (20+ min) | 108 | $11,709 | $66 |
| Long return visit (40+ min) | 59 | $10,832 | $131 |
| New patient visit (45+ min) | 75 | $10,226 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,933 | $187 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 12 | $3,393 | None |
| New patient visit (60+ min) | 18 | $3,022 | $168 |
| Short return visit | 22 | $2,148 | $40 |
| X-ray of hip, 2-3 views | 31 | $1,956 | $45 |
| New patient visit (30+ min) | 25 | $1,901 | $76 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 12 | $1,629 | $78 |
| X-ray of knee, 1-2 views | 27 | $1,188 | $34 |
| X-ray of shoulder, minimum of 2 views | 28 | $1,116 | $33 |
| X-ray of knee, 3 views | 23 | $1,084 | $37 |
| Aspiration and/or injection of fluid from large joint | 11 | $1,014 | $60 |
| X-ray of wrist, 2 views | 14 | $867 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 97 | $268 | None |
| Imaging guidance for procedure, 60 minutes or less | 14 | $199 | $14 |
2019: 15 services
| Return visit (30+ min) | 188 | $36,061 | $92 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 98 | $18,721 | $84 |
| Short return visit (20+ min) | 117 | $12,359 | $63 |
| New patient visit (45+ min) | 74 | $10,102 | $137 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 24 | $7,213 | None |
| Long return visit (40+ min) | 29 | $4,454 | $124 |
| Short return visit | 23 | $4,216 | $43 |
| New patient visit (60+ min) | 14 | $2,679 | $191 |
| Aspiration and/or injection of fluid from large joint | 28 | $2,609 | $51 |
| X-ray of knee, 1-2 views | 44 | $1,933 | $32 |
| New patient visit (30+ min) | 16 | $1,431 | $89 |
| X-ray of shoulder, minimum of 2 views | 21 | $808 | $28 |
| X-ray of hip, 2-3 views | 16 | $706 | $44 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 116 | $515 | None |
| Imaging guidance for procedure, 60 minutes or less | 16 | $234 | $14 |
2018: 16 services
| Return visit (30+ min) | 178 | $33,408 | $90 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 91 | $14,815 | $81 |
| New patient visit (45+ min) | 96 | $13,287 | $138 |
| Replacement of knee joint, both sides of knee | 11 | $13,026 | $1,184 |
| Short return visit (20+ min) | 108 | $10,721 | $65 |
| Long return visit (40+ min) | 22 | $3,930 | $123 |
| X-ray of knee, 1-2 views | 56 | $2,489 | $32 |
| Short return visit | 26 | $2,345 | $39 |
| New patient visit (30+ min) | 21 | $2,061 | $98 |
| New patient visit (60+ min) | 11 | $1,865 | $170 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,460 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,300 | $118 |
| X-ray of hip, 2-3 views | 14 | $807 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 117 | $695 | None |
| X-ray of shoulder, minimum of 2 views | 18 | $606 | $24 |
| Imaging guidance for procedure, 60 minutes or less | 34 | $345 | $10 |
2017: 21 services
| Return visit (30+ min) | 152 | $26,737 | $93 |
| Short return visit (20+ min) | 118 | $13,446 | $63 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 73 | $12,512 | $82 |
| Treatment of broken neck of thigh bone with bone implant | 11 | $12,174 | $1,107 |
| New patient visit (45+ min) | 73 | $9,980 | $137 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,718 | $168 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 14 | $3,886 | None |
| Long return visit (40+ min) | 26 | $3,742 | $125 |
| New patient visit (60+ min) | 12 | $2,060 | $172 |
| New patient visit (30+ min) | 16 | $1,607 | $100 |
| Short return visit | 23 | $1,585 | $36 |
| X-ray of knee, 1-2 views | 38 | $1,402 | $29 |
| X-ray of shoulder, minimum of 2 views | 26 | $986 | $27 |
| X-ray of hip, 2-3 views | 16 | $887 | $40 |
| X-ray of wrist, 2 views | 12 | $795 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 88 | $769 | None |
| Injection into tendon or ligament | 11 | $662 | $47 |
| X-ray of ankle, 2 views | 12 | $513 | $30 |
| X-ray of hip, 1 view | 12 | $391 | $30 |
| Imaging guidance for procedure, 60 minutes or less | 27 | $204 | $8 |
| Unclassified drugs | 40 | $5 | None |
2016: 16 services
| Short return visit (20+ min) | 173 | $30,466 | $62 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 75 | $16,483 | $82 |
| Treatment of broken neck of thigh bone with bone implant | 11 | $12,060 | $1,096 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 18 | $10,428 | None |
| Return visit (30+ min) | 55 | $6,311 | $90 |
| New patient visit (30+ min) | 51 | $4,842 | $95 |
| New patient visit (45+ min) | 30 | $3,775 | $126 |
| Emergency department visit with high level of medical decision making | 27 | $3,733 | $138 |
| X-ray of knee, 1-2 views | 41 | $1,621 | $29 |
| Short return visit | 32 | $1,427 | $41 |
| X-ray of hip, 2-3 views | 21 | $1,393 | $41 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,268 | $115 |
| X-ray of ankle, 2 views | 13 | $767 | $25 |
| X-ray of shoulder, minimum of 2 views | 14 | $537 | $28 |
| X-ray of pelvis, 1-2 views | 12 | $344 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 82 | $246 | None |
2015: 19 services
| Short return visit (20+ min) | 172 | $26,051 | $62 |
| Return visit (30+ min) | 98 | $15,008 | $97 |
| Treatment of broken neck of thigh bone with bone implant | 13 | $13,660 | $1,051 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 12 | $12,743 | $1,062 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 54 | $11,575 | $85 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 12 | $8,394 | None |
| Emergency department visit with high level of medical decision making | 47 | $6,731 | $143 |
| Removal of deep implant from bone | 13 | $4,235 | $303 |
| New patient visit (45+ min) | 30 | $4,102 | $137 |
| New patient visit (30+ min) | 47 | $3,939 | $84 |
| X-ray of knee, 1-2 views | 53 | $2,528 | $27 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,329 | $43 |
| X-ray of ankle, 2 views | 21 | $1,122 | $25 |
| Ultrasonic guidance for needle placement | 17 | $969 | $48 |
| X-ray of shoulder, minimum of 2 views | 22 | $830 | $25 |
| X-ray of ribs of one side of body, minimum of 2 views | 18 | $694 | $30 |
| X-ray of foot, minimum of 3 views | 11 | $484 | $27 |
| Imaging guidance for procedure, 60 minutes or less | 20 | $175 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $158 | None |
2014: 16 services
| Short return visit (20+ min) | 167 | $26,136 | $63 |
| Return visit (30+ min) | 108 | $15,185 | $89 |
| Ultrasonic guidance for needle placement | 82 | $12,374 | $70 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 20 | $12,281 | None |
| Aspiration and/or injection of fluid from large joint | 84 | $11,323 | $52 |
| New patient visit (45+ min) | 41 | $5,808 | $142 |
| New patient visit (30+ min) | 62 | $5,627 | $91 |
| Emergency department visit with high level of medical decision making | 22 | $3,171 | $144 |
| X-ray of knee, 1-2 views | 57 | $2,725 | $29 |
| X-ray of shoulder, minimum of 2 views | 35 | $1,680 | $30 |
| X-ray of ribs of one side of body, minimum of 2 views | 27 | $1,554 | $39 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,540 | $118 |
| X-ray of ankle, 2 views | 20 | $957 | $28 |
| X-ray of foot, minimum of 3 views | 13 | $820 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 81 | $213 | None |
| Imaging guidance for procedure, 60 minutes or less | 12 | $96 | $7 |
2013: 18 services
| Return visit (30+ min) | 146 | $24,380 | $88 |
| Short return visit (20+ min) | 168 | $23,262 | $65 |
| Treatment of broken neck of thigh bone with bone implant | 20 | $21,738 | $1,087 |
| Aspiration and/or injection of fluid from large joint | 89 | $17,478 | $47 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 33 | $12,834 | None |
| Ultrasonic guidance for needle placement | 37 | $12,658 | $211 |
| New patient visit (45+ min) | 66 | $9,114 | $138 |
| Emergency department visit with high level of medical decision making | 32 | $4,419 | $138 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,391 | $117 |
| New patient visit (30+ min) | 31 | $2,958 | $95 |
| X-ray of knee, 1-2 views | 57 | $2,254 | $29 |
| X-ray of ribs of one side of body, minimum of 2 views | 26 | $1,999 | $40 |
| X-ray of shoulder, minimum of 2 views | 24 | $1,428 | $31 |
| X-ray of foot, minimum of 3 views | 18 | $1,084 | $32 |
| X-ray of wrist, 2 views | 12 | $785 | $31 |
| X-ray of ankle, 2 views | 11 | $501 | $29 |
| Imaging guidance for procedure, 60 minutes or less | 36 | $268 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 80 | $204 | None |
Medicaid work
$673 in 2024
Medicaid paid $673 for 182 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 118 | $590 |
| DRAIN/INJ JOINT/BURSA W/US | 17 | $63 |
| Short return visit (20+ min) | 29 | $16 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $4 |
| 2024 | 182 | 4 | 19 | $673 |
| 2023 | 315 | 4 | 23 | $642 |
| 2022 | 508 | 4 | 28 | $687 |
| 2021 | 850 | 7 | 43 | $4,780 |
| 2020 | 2,035 | 14 | 132 | $5,921 |
| 2019 | 5,460 | 15 | 136 | $5,698 |
| 2018 | 1,023 | 10 | 39 | $1,800 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 154 | $374 |
| DRAIN/INJ JOINT/BURSA W/US | 33 | $206 |
| Short return visit (20+ min) | 82 | $55 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 46 | $6 |
2022
| Return visit (30+ min) | 188 | $333 |
| Short return visit (20+ min) | 206 | $246 |
| DRAIN/INJ JOINT/BURSA W/US | 30 | $92 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 84 | $16 |
2021
| New patient visit (30+ min) | 130 | $2,339 |
| Return visit (30+ min) | 122 | $1,035 |
| Short return visit (20+ min) | 335 | $878 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 43 | $349 |
| DRAIN/INJ JOINT/BURSA W/US | 100 | $164 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 105 | $15 |
| Lidocaine injection | 15 | $0 |
2020
| Return visit (30+ min) | 688 | $2,704 |
| New patient visit (30+ min) | 220 | $1,737 |
| Short return visit (20+ min) | 390 | $684 |
| New patient visit (45+ min) | 134 | $626 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 115 | $105 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 17 | $19 |
| DRAIN/INJ JOINT/BURSA W/US | 66 | $16 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 19 | $14 |
| Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (IPPB) device | 24 | $12 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 36 | $4 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 14 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 180 | $0 |
2019
| Return visit (30+ min) | 1,651 | $2,376 |
| New patient visit (45+ min) | 742 | $1,913 |
| Short return visit (20+ min) | 341 | $416 |
| DRAIN/INJ JOINT/BURSA W/US | 153 | $323 |
| New patient visit (30+ min) | 542 | $296 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 180 | $233 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 202 | $75 |
| Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (IPPB) device | 229 | $47 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 240 | $12 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 65 | $7 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 104 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 120 | $0 |
2018
| Return visit (30+ min) | 404 | $1,066 |
| New patient visit (45+ min) | 80 | $276 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 41 | $147 |
| Short return visit (20+ min) | 115 | $138 |
| New patient visit (30+ min) | 51 | $126 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | $46 |
| DRAIN/INJ JOINT/BURSA W/US | 31 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 20 | $0 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 67 | $0 |
| Services provided in an urgent care center (list in addition to code for service) | 162 | $0 |
Drugs they prescribed that Part D paid
$45,813
Pharmacies billed $45,813 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 45% of their Part D prescriptions (501 of 1,127) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Long-acting opioids: 4% of their opioid prescriptions.
1,095 generic and 32 brand-name prescriptions · $45,813 in drug cost · 18 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycontin | 13 | $15,180 | $1,168 |
| Hydrocodone-Acetaminophen | 342 | $7,514 | $22 |
| Lidocaine | 26 | $3,572 | $137 |
| Gabapentin | 126 | $1,524 | $12 |
| Diclofenac | 80 | $1,453 | $18 |
See all 18 drugs
| Oxycontin | 13 | $15,180 | $1,168 |
| Hydrocodone-Acetaminophen | 342 | $7,514 | $22 |
| Lidocaine | 26 | $3,572 | $137 |
| Gabapentin | 126 | $1,524 | $12 |
| Diclofenac | 80 | $1,453 | $18 |
| Oxycodone-Acetaminophen | 41 | $1,224 | $30 |
| Oxycodone | 43 | $916 | $21 |
| Celecoxib | 37 | $429 | $12 |
| Pregabalin | 21 | $358 | $17 |
| Ibuprofen | 48 | $323 | $7 |
| Methylprednisolone | 45 | $309 | $7 |
| Carisoprodol | 21 | $183 | $9 |
| Tramadol | 52 | $149 | $3 |
| Meloxicam | 32 | $125 | $4 |
| Alprazolam | 23 | $106 | $5 |
| Cyclobenzaprine | 17 | $69 | $4 |
| Alendronate | 11 | $64 | $6 |
| Prednisone | 17 | $40 | $2 |
Year by year
| 2024 | 1,127 | 192 | 45% (501) | 3% | $45,813 |
| 2023 | 1,502 | 207 | 43% (638) | 7% | $141,326 |
| 2022 | 1,564 | 215 | 46% (723) | None | $68,158 |
| 2021 | 1,512 | 205 | 45% (678) | None | $49,103 |
| 2020 | 1,290 | 200 | 44% (571) | 3% | $43,323 |
| 2019 | 959 | 174 | 34% (323) | 8% | $55,792 |
| 2018 | 885 | 185 | 35% (310) | 10% | $46,148 |
| 2017 | 962 | 165 | 41% (396) | 8% | $45,369 |
| 2016 | 783 | 145 | 42% (329) | 9% | $53,604 |
| 2015 | 725 | 134 | 36% (262) | None | $41,344 |
| 2014 | 561 | 117 | 42% (233) | None | $49,055 |
| 2013 | 845 | 138 | 44% (370) | None | $59,285 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Ozempic | 67 | $70,694 | $1,055 |
| Oxycontin | 13 | $17,875 | $1,375 |
| Hydrocodone-Acetaminophen | 393 | $12,211 | $31 |
| Diclofenac | 181 | $8,039 | $44 |
| Eliquis | 17 | $3,735 | $220 |
| Lidocaine | 19 | $3,264 | $172 |
| Oxycodone-Acetaminophen | 92 | $2,694 | $29 |
| Gabapentin | 125 | $2,200 | $18 |
| Oxycodone | 87 | $2,092 | $24 |
| Celecoxib | 47 | $1,674 | $36 |
| Carisoprodol | 29 | $839 | $29 |
| Pregabalin | 32 | $764 | $24 |
| Meloxicam | 53 | $545 | $10 |
| Indomethacin | 17 | $538 | $32 |
| Ibuprofen | 36 | $487 | $14 |
| Methylprednisolone | 36 | $454 | $13 |
| Cephalexin | 19 | $288 | $15 |
| Tramadol | 48 | $262 | $5 |
| Alprazolam | 23 | $224 | $10 |
| Cyclobenzaprine | 14 | $153 | $11 |
| Promethazine | 11 | $130 | $12 |
| Zolpidem | 12 | $105 | $9 |
| Prednisone | 14 | $81 | $6 |
| Alendronate | 12 | $79 | $7 |
2022: 20 drugs
| Oxycontin | 13 | $16,010 | $1,232 |
| Ozempic | 15 | $14,005 | $934 |
| Hydrocodone-Acetaminophen | 473 | $11,104 | $23 |
| Diclofenac | 190 | $5,270 | $28 |
| Oxycodone-Acetaminophen | 95 | $3,263 | $34 |
| Celecoxib | 51 | $2,483 | $49 |
| Oxycodone | 61 | $2,453 | $40 |
| Gabapentin | 168 | $2,305 | $14 |
| Pregabalin | 39 | $1,208 | $31 |
| Carisoprodol | 32 | $978 | $31 |
| Ibuprofen | 36 | $444 | $12 |
| Meloxicam | 66 | $389 | $6 |
| Cyclobenzaprine | 31 | $359 | $12 |
| Tramadol | 72 | $253 | $4 |
| Methylprednisolone | 30 | $238 | $8 |
| Naproxen | 27 | $205 | $8 |
| Zolpidem | 13 | $100 | $8 |
| Alprazolam | 13 | $90 | $7 |
| Lorazepam | 15 | $81 | $5 |
| Alendronate | 13 | $79 | $6 |
2021: 21 drugs
| Oxycontin | 12 | $16,166 | $1,347 |
| Hydrocodone-Acetaminophen | 453 | $11,174 | $25 |
| Diclofenac | 219 | $4,293 | $20 |
| Gabapentin | 164 | $2,193 | $13 |
| Oxycodone-Acetaminophen | 76 | $1,695 | $22 |
| Oxycodone | 61 | $1,624 | $27 |
| Pregabalin | 54 | $1,502 | $28 |
| Celecoxib | 32 | $900 | $28 |
| Carisoprodol | 25 | $787 | $31 |
| Cyclobenzaprine | 39 | $441 | $11 |
| Ibuprofen | 43 | $397 | $9 |
| Methylprednisolone | 34 | $347 | $10 |
| Baclofen | 11 | $253 | $23 |
| Acetaminophen-Codeine | 17 | $232 | $14 |
| Tramadol | 58 | $175 | $3 |
| Naproxen | 28 | $174 | $6 |
| Meloxicam | 36 | $173 | $5 |
| Alendronate | 18 | $135 | $8 |
| Alprazolam | 26 | $113 | $4 |
| Lorazepam | 19 | $92 | $5 |
| Prednisone | 17 | $81 | $5 |
2020: 19 drugs
| Oxycontin | 13 | $16,341 | $1,257 |
| Hydrocodone-Acetaminophen | 403 | $8,930 | $22 |
| Diclofenac | 167 | $3,305 | $20 |
| Oxycodone-Acetaminophen | 60 | $2,005 | $33 |
| Gabapentin | 171 | $1,958 | $11 |
| Pregabalin | 39 | $1,720 | $44 |
| Oxycodone | 50 | $1,412 | $28 |
| Celecoxib | 33 | $710 | $22 |
| Ibuprofen | 34 | $335 | $10 |
| Cyclobenzaprine | 33 | $272 | $8 |
| Methylprednisolone | 28 | $256 | $9 |
| Carisoprodol | 18 | $243 | $13 |
| Meloxicam | 36 | $159 | $4 |
| Lorazepam | 30 | $137 | $5 |
| Tramadol | 35 | $127 | $4 |
| Naproxen | 23 | $126 | $5 |
| Cephalexin | 13 | $126 | $10 |
| Diclofenac Sodium Er | 11 | $69 | $6 |
| Alprazolam | 11 | $42 | $4 |
2019: 21 drugs
| Oxycontin | 11 | $12,864 | $1,169 |
| Lyrica | 22 | $12,423 | $565 |
| Hydrocodone-Acetaminophen | 173 | $4,720 | $27 |
| Diclofenac | 157 | $3,716 | $24 |
| Oxycodone-Acetaminophen | 63 | $3,194 | $51 |
| Gabapentin | 141 | $2,753 | $20 |
| Oxycodone | 45 | $1,927 | $43 |
| Voltaren | 26 | $1,386 | $53 |
| Celecoxib | 12 | $1,260 | $105 |
| Carisoprodol | 22 | $295 | $13 |
| Ibuprofen | 24 | $284 | $12 |
| Baclofen | 11 | $279 | $25 |
| Methylprednisolone | 22 | $272 | $12 |
| Cyclobenzaprine | 20 | $258 | $13 |
| Diclofenac Sodium Er | 13 | $136 | $10 |
| Lorazepam | 25 | $135 | $5 |
| Naproxen | 16 | $126 | $8 |
| Omeprazole | 15 | $84 | $6 |
| Alprazolam | 11 | $74 | $7 |
| Tramadol | 23 | $70 | $3 |
| Meloxicam | 11 | $55 | $5 |
2018: 21 drugs
| Lyrica | 27 | $12,078 | $447 |
| Oxycontin | 11 | $11,783 | $1,071 |
| Hydrocodone-Acetaminophen | 180 | $4,757 | $26 |
| Diclofenac | 110 | $2,752 | $25 |
| Oxycodone-Acetaminophen | 54 | $2,036 | $38 |
| Gabapentin | 124 | $1,805 | $15 |
| Voltaren | 25 | $1,578 | $63 |
| Oxycodone | 23 | $1,128 | $49 |
| Omeprazole | 15 | $319 | $21 |
| Tramadol | 29 | $222 | $8 |
| Ibuprofen | 16 | $202 | $13 |
| Meloxicam | 22 | $200 | $9 |
| Methylprednisolone | 14 | $196 | $14 |
| Alendronate | 20 | $161 | $8 |
| Cephalexin | 11 | $159 | $14 |
| Carisoprodol | 14 | $157 | $11 |
| Baclofen | 11 | $152 | $14 |
| Alprazolam | 19 | $135 | $7 |
| Naproxen | 14 | $121 | $9 |
| Lorazepam | 23 | $97 | $4 |
| Temazepam | 12 | $78 | $7 |
2017: 22 drugs
| Lyrica | 25 | $11,219 | $449 |
| Hydrocodone-Acetaminophen | 234 | $6,252 | $27 |
| Oxycodone-Acetaminophen | 73 | $3,940 | $54 |
| Diclofenac | 103 | $1,661 | $16 |
| Gabapentin | 104 | $1,173 | $11 |
| Celecoxib | 13 | $1,114 | $86 |
| Voltaren | 20 | $1,087 | $54 |
| Oxycodone | 24 | $1,003 | $42 |
| Baclofen | 17 | $295 | $17 |
| Carisoprodol | 30 | $254 | $8 |
| Tramadol | 40 | $233 | $6 |
| Methylprednisolone | 12 | $181 | $15 |
| Ibuprofen | 18 | $160 | $9 |
| Naproxen | 19 | $137 | $7 |
| Omeprazole | 18 | $129 | $7 |
| Alendronate | 20 | $128 | $6 |
| Alprazolam | 18 | $111 | $6 |
| Meloxicam | 15 | $91 | $6 |
| Lorazepam | 21 | $84 | $4 |
| Diazepam | 15 | $81 | $5 |
| Cephalexin | 12 | $79 | $7 |
| Temazepam | 12 | $78 | $7 |
2016: 17 drugs
| Hydrocodone-Acetaminophen | 212 | $8,989 | $42 |
| Lyrica | 26 | $8,299 | $319 |
| Oxycodone-Acetaminophen | 73 | $6,053 | $83 |
| Gabapentin | 88 | $1,972 | $22 |
| Morphine Sulfate Er | 13 | $1,658 | $128 |
| Celecoxib | 15 | $1,632 | $109 |
| Diclofenac | 42 | $930 | $22 |
| Carisoprodol | 26 | $345 | $13 |
| Omeprazole | 29 | $309 | $11 |
| Ibuprofen | 19 | $191 | $10 |
| Naproxen | 16 | $165 | $10 |
| Lorazepam | 21 | $130 | $6 |
| Zolpidem | 11 | $118 | $11 |
| Diazepam | 15 | $100 | $7 |
| Alprazolam | 14 | $94 | $7 |
| Temazepam | 12 | $78 | $7 |
| Clonazepam | 11 | $33 | $3 |
2015: 17 drugs
| Lyrica | 25 | $7,568 | $303 |
| Hydrocodone-Acetaminophen | 178 | $7,450 | $42 |
| Oxycodone-Acetaminophen | 57 | $4,473 | $78 |
| Lidocaine | 13 | $2,891 | $222 |
| Celecoxib | 16 | $2,107 | $132 |
| Gabapentin | 86 | $1,987 | $23 |
| Zolpidem Tartrate Er | 11 | $1,414 | $129 |
| Voltaren | 18 | $1,318 | $73 |
| Diclofenac | 34 | $868 | $26 |
| Diclofenac Sodium Er | 13 | $474 | $36 |
| Carisoprodol | 13 | $381 | $29 |
| Omeprazole | 33 | $323 | $10 |
| Ibuprofen | 19 | $173 | $9 |
| Cephalexin | 15 | $164 | $11 |
| Famotidine | 12 | $111 | $9 |
| Temazepam | 12 | $78 | $7 |
| Diazepam | 19 | $73 | $4 |
2014: 12 drugs
| Lyrica | 37 | $9,755 | $264 |
| Celebrex | 22 | $9,440 | $429 |
| Hydrocodone-Acetaminophen | 158 | $4,318 | $27 |
| Lidoderm | 12 | $3,029 | $252 |
| Oxycodone-Acetaminophen | 32 | $2,576 | $81 |
| Voltaren | 19 | $1,358 | $71 |
| Diclofenac | 59 | $1,247 | $21 |
| Gabapentin | 49 | $1,042 | $21 |
| Carisoprodol | 12 | $223 | $19 |
| Omeprazole | 17 | $206 | $12 |
| Acetaminophen-Codeine | 11 | $145 | $13 |
| Tramadol | 14 | $98 | $7 |
2013: 17 drugs
| Lyrica | 64 | $14,358 | $224 |
| Lidoderm | 22 | $6,970 | $317 |
| Hydrocodone-Acetaminophen | 233 | $3,932 | $17 |
| Voltaren | 27 | $2,001 | $74 |
| Oxycodone Hcl-Acetaminophen | 55 | $1,917 | $35 |
| Diclofenac | 55 | $1,830 | $33 |
| Gabapentin | 79 | $1,677 | $21 |
| Zolpidem Tartrate Er | 12 | $1,460 | $122 |
| Carisoprodol | 21 | $378 | $18 |
| Acetaminophen-Codeine | 21 | $238 | $11 |
| Oxycodone | 13 | $212 | $16 |
| Omeprazole | 14 | $205 | $15 |
| Naproxen | 17 | $167 | $10 |
| Lorazepam | 13 | $142 | $11 |
| Oxycodone-Acetaminophen | 16 | $138 | $9 |
| Ibuprofen | 18 | $132 | $7 |
| Zolpidem | 13 | $67 | $5 |
Money from drug and device companies
$12 in 2022
| 2022 | 1 | 1 | None | $12 |
| 2021 | 1 | 7 | None | $723 |
| 2020 | 1 | 5 | None | $383 |
| 2019 | 4 | 13 | None | $1,248 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ethicon US | Stratafix | $12 | 1 payment
|
See the published payment
| Ethicon US | Meals · 2022-11-18 | Stratafix | $12 |
See earlier years (2021, 2020, 2019)
2021: $723
| Stryker | Mako | $723 | 7 payments
|
2020: $383
| Stryker | Mako | $383 | 5 payments
|
2019: $1,248
| Stryker | Mako | $1,179 | 10 payments
|
| DePuy Synthes Sales | Headless Compression Screws | $44 | 1 payment
|
| Boston Scientific | General Therapies | $13 | 1 payment
|
| Osiris Therapeutics | Stravix | $12 | 1 payment
|
Checkups this office reported
16 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 93.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 50%That's more than half. | 531 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 71%That's more than half. | 56 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 1%That's few of the people this applied to. Better on this measure. | 112 |
| Breast cancer screeningEligible women who got a mammogram | 23%That's few of the people this applied to. | 246 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 12%That's few of the people this applied to. | 226 |
| Checked for fall riskOlder patients screened for fall risk | 6%That's few of the people this applied to. | 325 |
| Colon cancer screeningEligible adults who got a colon cancer test | 9%That's few of the people this applied to. | 496 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 3%That's few of the people this applied to. | 690 |
See the other 8 measures
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 0%That's few of the people this applied to. | 22 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 77%That's most of the people this applied to. Worse on this measure. | 22 |
| HIV screeningEligible patients who were screened for HIV | 12%That's few of the people this applied to. | 484 |
| Medications listed in the chartVisits where the current medication list was documented | 28%That's less than half. | 1,855 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 377 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 99%That's most of the people this applied to. | 636 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 83%That's most of the people this applied to. | 116 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 76%That's most of the people this applied to. | 774 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
Professional record
- NPI
- 1780689406
- Licence
- CA A054508, FL ME84652Florida ME84652: Active
- Group
- Bass Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- FL 264598000
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 6140 Camino Verde Dr Ste L, San Jose, CA, 95119
- NPI first listed
- 2005-06-17
- NPI last updated
- 2025-01-03
- NPI record certified
- 2025-01-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4200 Douglas Blvd # 200, Granite Bay, CA, 95746